Pylarify drug
Ended Awarded Last action
- Contract number
- 36C25523N0196
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $765,049
Award facts
- Contract value 100% obligated
- $765,048.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$234,567 | |
| Original award | $999,615 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer positron emission tomography (PET) imaging. The contract, valued at $765,048.64, has a period of performance through February 29, 2024. PYLARIFY is the flagship product of Progenics Pharmaceuticals, a pharmaceutical company specializing in innovative diagnostic agents and targeted therapeutics for oncology. This BPA contract, which is not set-aside, allows various VA medical facilities across the Veterans Integrated Service Network (VISN) 15 to order PYLARIFY as needed to support their cancer imaging and treatment programs. The contract is primarily funded through the VA's medical procurement budget.
Quick answers
Who was awarded contract 36C25523N0196?
36C25523N0196 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 1, 2023.
How much is contract 36C25523N0196 worth?
The government has obligated $765,049 on 36C25523N0196.
Is contract 36C25523N0196 an order under another contract?
Yes. 36C25523N0196 is a BPA call under 36F79719D0170-36C25523A0018, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25523N0196 competed?
The extent of competition for 36C25523N0196 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award